$VMCA
Valuence Merger Corp I Stock $vmca

$vmca Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222031090 Filed on November 09, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.162M	$949.0K
YoY Change
Operating Profit		-$949.0K	-$4.920K
YoY Change		19187.62%
Interest Expense	$1.898M	$1.059M
YoY Change
% of Operating Profit
Other Income/Expense, Net		$1.059M
YoY Change
Pretax Income	$735.7K	$110.5K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	$735.7K	$110.5K	-$4.920K
YoY Change		-2345.79%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.03	$4.016K
COMMON SHARES
Basic Shares Outstanding	22.01M shares	22.01M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$319.2K	$463.3K
YoY Change
Cash & Equivalents	$319.2K	$463.3K
Short-Term Investments
Other Short-Term Assets	$522.4K	$641.4K
YoY Change
Inventory
Prepaid Expenses	$522.4K	$641.4K
Receivables
Other Receivables
Total Short-Term Assets	$841.6K	$1.105M
YoY Change	370.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.000M	$5.000M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$229.9M	$228.1M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$229.9M	$228.1M
YoY Change	50243.28%
TOTAL ASSETS
Total Short-Term Assets	$841.6K	$1.105M
Total Long-Term Assets	$229.9M	$228.1M
Total Assets	$230.8M	$229.2M
YoY Change	36218.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.989M	$1.090M
YoY Change
Accrued Expenses	$70.00K	$70.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.258M	$1.359M
YoY Change	263.94%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$8.105M	$8.105M
YoY Change
Total Long-Term Liabilities	$8.105M	$8.105M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.258M	$1.359M
Total Long-Term Liabilities	$8.105M	$8.105M
Total Liabilities	$10.36M	$9.464M
YoY Change	1570.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.522M	-$8.360M
YoY Change	95793.64%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.522M	-$8.359M	-$4.920K
YoY Change
Total Liabilities & Shareholders Equity	$230.8M	$229.2M
YoY Change	36218.72%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	$735.7K	$110.5K	-$4.920K
YoY Change		-2345.79%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$144.1K	-$81.51K	-$4.920K
YoY Change		1556.71%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	$4.920K
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-144.1K	-81.51K	-$4.920K
Cash From Investing Activities	0.000	0.000
Cash From Financing Activities	0.000	0.000	$4.920K
Net Change In Cash	-144.1K	-81.51K
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$144.1K	-$81.51K	-$4.920K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Deferred Costs DeferredCosts		usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent		usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent		usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent		usd
CY2021Q4	VMCAU	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent		usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001892747
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2021Q3	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther		usd
CY2021Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
CY2021Q3	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits		usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2021Q3	VMCAU	Proceeds From Sale Of Units Net Of Underwriting Discounts Paid ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid		usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2021Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2021Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect		usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2021Q3	VMCAU	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts		usd
CY2021Q3	VMCAU	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41304
	dei	Entity Registrant Name EntityRegistrantName	VALUENCE MERGER CORP. I
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4 Orinda Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100D
	dei	Entity Address City Or Town EntityAddressCityOrTown	Orinda
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94563
	dei	City Area Code CityAreaCode	(415)
	dei	Local Phone Number LocalPhoneNumber	340-0222
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22009963	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	463269	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	178698	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	641413	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	1104682	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	178698	usd
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	456764	usd
CY2022Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	228052068	usd
CY2022Q3	us-gaap	Assets Assets	229156750	usd
CY2021Q4	us-gaap	Assets Assets	635462	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1090247	usd
CY2022Q3	VMCAU	Accrued Offering Costs Current AccruedOfferingCostsCurrent	70000	usd
CY2021Q4	VMCAU	Accrued Offering Costs Current AccruedOfferingCostsCurrent	320015	usd
CY2022Q3	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	198384	usd
CY2021Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	377	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	300000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1358631	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	620392	usd
CY2022Q3	VMCAU	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	8105480	usd
CY2022Q3	us-gaap	Liabilities Liabilities	9464111	usd
CY2021Q4	us-gaap	Liabilities Liabilities	620392	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	228052068	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	VMCAU	Adjustments To Additional Paid In Capital Fair Value Of Public Warrants Net Of Transaction Costs AdjustmentsToAdditionalPaidInCapitalFairValueOfPublicWarrantsNetOfTransactionCosts	5617513	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24425	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8359979	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9930	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-8359429	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15070	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	229156750	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	635462	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	948951	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1454509	usd
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4920	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-948951	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1454509	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4920	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1059444	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1349448	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1059444	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1349448	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	110493	usd
	us-gaap	Net Income Loss NetIncomeLoss	-105061	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4920	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15070	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	10401993	usd
CY2022Q1	VMCAU	Adjustments To Additional Paid In Capital Accretion Of Common Stock Subject To Redemption AdjustmentsToAdditionalPaidInCapitalAccretionOfCommonStockSubjectToRedemption	-22939495	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-82271	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-6987190	usd
CY2022Q2	VMCAU	Adjustments To Additional Paid In Capital Accretion Of Common Stock Subject To Redemption AdjustmentsToAdditionalPaidInCapitalAccretionOfCommonStockSubjectToRedemption	-290004	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-133283	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-7410477	usd
CY2022Q3	VMCAU	Adjustments To Additional Paid In Capital Accretion Of Common Stock Subject To Redemption AdjustmentsToAdditionalPaidInCapitalAccretionOfCommonStockSubjectToRedemption	-1059445	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	110493	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-8359429	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4920	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4920	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-4920	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-4920	usd
	us-gaap	Net Income Loss NetIncomeLoss	-105061	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4920	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1349448	usd
CY2022Q3	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	814510	usd
	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	2200996	usd
	VMCAU	Deferred Underwriting Fees DeferredUnderwritingFees	8105480	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	641413	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1090247	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1005675	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4920	usd
	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	226702620	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-226702620	usd
	VMCAU	Proceeds From Sale Of Units Net Of Underwriting Discounts Paid ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid	218300626	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10401993	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	198007	usd
CY2021Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	4920	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	300000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	607760	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	227992866	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4920	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	284571	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	178698	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	463269	usd
	VMCAU	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts	250015	usd
	VMCAU	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	8105480	usd
CY2022Q1	us-gaap	Deposits Deposits	20702619	usd
CY2022Q1	VMCAU	Deposits Per Unit DepositsPerUnit	10.30
CY2022Q1	VMCAU	Proceeds From Deposit Held In Trust Account ProceedsFromDepositHeldInTrustAccount	226702619	usd
	VMCAU	Transaction Costs TransactionCosts	10718994	usd
	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	4000000	usd
	VMCAU	Percentage Assets Held In The Trust Account PercentageAssetsHeldInTheTrustAccount	0.80	pure
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5000001	usd
	VMCAU	Payment To Dissolution Expenses PaymentToDissolutionExpenses	100000	usd
CY2022Q3	us-gaap	Share Price SharePrice	10.00
CY2022Q3	us-gaap	Cash Cash	463269	usd
CY2022Q3	VMCAU	Working Capital WorkingCapital	253949	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_z3caxxiBBN7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zNrIvdAx0oVc">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Cash Cash	463269	usd
CY2021Q4	us-gaap	Cash Cash	178698	usd
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q1	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	220099630	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	5942690	usd
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-10393817	usd
CY2022Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	22939496	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	1349449	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	228052068	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q3	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_z5XRFLInxaHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zp4QB1SxpHEh">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_c20220930_zAVXqDw0GNjc" title="Cash FDIC insured amount">250,000</span>. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2021Q4	us-gaap	Related Party Costs RelatedPartyCosts	25000	usd
CY2021Q4	VMCAU	Common Stock Shares Subject To Forfeiture CommonStockSharesSubjectToForfeiture	750000	shares
	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	(A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	1500000	usd
CY2022Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	198384	usd
CY2022Q3	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	198384	usd
CY2021Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	377	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	VMCAU	Equity Proceeds Percentage EquityProceedsPercentage	0.60	pure
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

Files In Submission

Name	View Source	Status
vmcau-20220930_cal.xml	Edgar Link	unprocessable
0001493152-22-031090-index-headers.html	Edgar Link	pending
0001493152-22-031090-index.html	Edgar Link	pending
0001493152-22-031090.txt	Edgar Link	pending
0001493152-22-031090-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vmcau-20220930.xsd	Edgar Link	pending
vmcau-20220930_def.xml	Edgar Link	unprocessable
vmcau-20220930_pre.xml	Edgar Link	unprocessable
vmcau-20220930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VMCA
Valuence Merger Corp I Stock $vmca

2022 Q4 Form 10-Q Financial Statement

#000149315222031090 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VMCA Valuence Merger Corp I Stock $vmca

2022 Q4 Form 10-Q Financial Statement

#000149315222031090 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VMCA
Valuence Merger Corp I Stock $vmca